By Tom Zanki ( April 23, 2015, 5:03 PM EDT) -- Weight-loss capsule developer Gelesis Inc. set terms Thursday for an initial public offering that could raise $52 million, proceeds the biotech said it would use partly to advance its lead product candidate to treat patients with obesity and Type 2 diabetes....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.